晚期卵巢癌多脏器腹膜整块全腹膜后切除术(TROMP)的评估:单中心队列研究
这项单中心回顾性队列研究纳入2017年1月至2023年12月间接受TROMP原发肿瘤细胞减灭术的75例FIGO III-IV期上皮性卵巢癌患者,评估围手术期并发症、辅助治疗及生存结局。完全细胞减灭率达86.7%,中位随访31个月时中位无进展生存期(PFS)为30个月、中位总生存期(OS)为77个月,作者认为该术式切除率高、并发症可接受且生存结局有前景。
要点
- 75例FIGO III-IV期上皮性卵巢癌患者接受TROMP术,完全细胞减灭率为86.7%。
- 中位随访31个月,中位PFS为30个月,中位OS为77个月。
- 2年、3年、5年PFS率分别为57.2%、48.8%、22.6%;OS率分别为85.6%、73.6%、60.8%。
核心结论
- TROMP术在晚期卵巢癌患者中显示出高完全切除率、可接受的并发症发生率和有前景的生存结局。
- 作者认为这些良好结果可能不仅归因于细胞减灭范围,还归因于系统切除腹膜表面(包括肉眼正常者)及可能减少肿瘤细胞播散的无接触手术方式。
- 作者认为这些发现支持该技术此前报告的手术和肿瘤学结局的可重复性。
研究设计与样本
- 单中心回顾性队列研究,纳入2017年1月至2023年12月间接受TROMP原发肿瘤细胞减灭术的75例FIGO III-IV期上皮性卵巢癌患者。
- TROMP术式包括系统整块切除壁层腹膜以清除可见及潜在显微镜下病灶。
- 收集围手术期并发症、辅助治疗及生存数据,术后并发症采用Clavien-Dindo分类评估,生存采用Kaplan-Meier法估计。
主要发现
- 完全细胞减灭率达86.7%。
- 中位随访31个月时,中位PFS为30个月,中位OS为77个月。
- 估计2年、3年、5年PFS率分别为57.2%、48.8%、22.6%。
- 估计2年、3年、5年OS率分别为85.6%、73.6%、60.8%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the oncologic and surgical outcomes of the Total Retroperitoneal en-Bloc Resection of Multivisceral-Peritoneal Packet (TROMP) technique in patients with advanced epithelial ovarian cancer. METHODS: This retrospective cohort study included 75 patients with FIGO stage III-IV epithelial ovarian cancer who underwent primary cytoreductive surgery using the TROMP approach between January 2017 and December 2023. The TROMP procedure involved systematic en-bloc resection of the parietal peritoneum to eliminate both visible and potential microscopic disease. Perioperative morbidity, adjuvant treatment, and survival data were collected. Postoperative complications were assessed using the Clavien-Dindo classification, and survival was estimated with the Kaplan-Meier method. RESULTS: Complete cytoreduction was achieved in 86.7 % of patients. At a median follow-up of 31 months, the median progression-free survival (PFS) was 30 months and median overall survival (OS) was 77 months. The estimated 2-, 3-, and 5-year PFS rates were 57.2 %, 48.8 %, and 22.6 %, respectively, while 2-, 3-, and 5-year OS rates were 85.6 %, 73.6 %, and 60.8 %. CONCLUSIONS: The TROMP procedure demonstrated high rates of complete resection with acceptable morbidity and promising survival outcomes in patients with advanced ovarian cancer. These favorable results may be attributed not only to the extent of cytoreduction, but also to the systematic removal of peritoneal surfaces, including those appearing macroscopically normal, and the use of a no-touch surgical approach that may help reduce tumor cell dissemination. These findings support the reproducibility of the surgical and oncologic outcomes previously reported for this technique.
引用
- Sozen H, Minareci Y, Toyran A, et al. Evaluation of total retroperitoneal en-bloc resection of multivisceral-peritoneal packet (TROMP) in advanced ovarian cancer: A single-center cohort study. Gynecol Oncol. 2025. PMID: 40839956. doi:10.1016/j.ygyno.2025.08.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。